AdoRx Therapeutics announces initial funding of $10 million for the discovery of new cancer therapeutics

AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million investment round financed by Epidarex Capital and CRT Pioneer Fund (‘CPF’).

June 21, 2018
View the Post